Identification of Immune-Related Genes and Small-Molecule Drugs in Interstitial Cystitis/Bladder Pain Syndrome Based on the Integrative Machine Learning Algorithms and Molecular Docking

<div>Docking diagram of potential small-molecule drugs with targets. (a) bumetanide-RASGRP1. (b) dibenzoylmethane-RASGRP1. (c) dibenzoylmethane-RBP4.</div>

Journal of Immunology Research

fig9

Figure 9

Figure 9: Identification of Immune-Related Genes and Small-Molecule Drugs in Interstitial Cystitis/Bladder Pain Syndrome Based on the Integrative Machine Learning Algorithms and Molecular Docking 

Figure 9 | Identification of Immune-Related Genes and Small-Molecule Drugs in Interstitial Cystitis/Bladder Pain Syndrome Based on the Integrative Machine Learning Algorithms and Molecular Docking 